<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03976791</url>
  </required_header>
  <id_info>
    <org_study_id>2019KYPJ078</org_study_id>
    <nct_id>NCT03976791</nct_id>
  </id_info>
  <brief_title>A Randomized Controlled Study of Phacoemulsification by the Enlarged Internal Incision and the Regular 2.2mm Incision</brief_title>
  <official_title>A Randomized Controlled Study of Phacoemulsification by the Enlarged Internal Incision and the Regular 2.2mm Incision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zhongshan Ophthalmic Center, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongshan Ophthalmic Center, Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective and Principle: To evaluate whether enlarging the incision can reduce corneal
      complications associated with phacoemulsification with regular 2.2 mm incision.

      The aim of this study: To evaluate whether the technique of enlarging internal incision could
      reduce the incidence of descemet membrane detachment after 2.2 mm incision
      phacoemulsification.

      Secondary outcome: To evaluate whether the technique of enlarged internal incision can reduce
      other corneal complications such as corneal edema and astigmatism after 2.2 mm incision
      phacoemulsification.

      Study Design: A prospective randomized controlled study
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>descemet membrane detachment(DMD)</measure>
    <time_frame>postoperative 1 week</time_frame>
    <description>DMD at the incision observed by anterior segment optical coherence tomography</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">294</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Enlarged internal incision</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>enlarged the internal incision about 0.4mm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Regular 2.2mm incision</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>regular 2.2mm corneal incision for microincision coaxial phacoemulsification</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>enlarged internal incision</intervention_name>
    <description>enlarging the internal incision about 0.4mm</description>
    <arm_group_label>Enlarged internal incision</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>regular 2.2mm incision</intervention_name>
    <description>2.2mm microincision coaxial phacoemulsification</description>
    <arm_group_label>Regular 2.2mm incision</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age-related cataract patients

          -  Age from 65 to 90

          -  The diameter of pupil after mydriasis is more than 6 mm

          -  LOCS III nuclear grade â‰¥4

          -  Corneal endothelial cell count &gt; 1500 cells/mm2

          -  Phacoemulsification and intraocular lens implantation are planned

          -  Agree to participate in this study and sign informed consent

        Exclusion Criteria:

          -  History of ocular trauma

          -  Anterior segment lesions (exfoliation syndrome, suspension ligament injury or
             relaxation, corneal and iris lesions, glaucoma)

          -  Other ocular diseases that impair visual function, such as optic neuropathy, uveitis
             and ocular tumors

          -  History of Ophthalmic Surgery

          -  Intraoperative and Postoperative Complications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yizhi Liu, Doctor</last_name>
    <phone>87330475</phone>
    <email>liuyizh@mail.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yizhi Liu, Doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 4, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

